ASH Clinical News Editor-in-Chief Aaron Gerds, MD, previews the upcoming May issue of the magazine. Highlights include a feature on the practice of "bagging" drugs, coverage on using MRD testing to identify patients with NPM1-mutated AML who may benefit from transplant, and a perspectives piece on favorable responses in FLT3-mutated AML to a triplet regimen including an inhibitor. Stay tuned for the issue's publication on May 6!